‹ Back to the directory

Biography

Eloïse Berson is a researcher specializing in the application of artificial intelligence and deep learning methods to translational medicine and systems biology. Her work focuses on multiomic analysis and the integration of clinical data to improve risk stratification, predict clinical outcomes, and understand the mechanisms underlying complex diseases. She has contributed to the development of innovative models, such as tools for deconvolving epigenomic and transcriptomic data (e.g., Cellformer) to identify specific cellular signatures associated with conditions such as Alzheimer’s disease or cognitive resilience. Her research also addresses complications of neonatal prematurity, where she has helped create predictive metabolic indices (e.g., *metabolic health index*) to assess the risks of bronchopulmonary dysplasia or necrotizing enterocolitis, by combining deep learning approaches with neonatal screening data. More recently, her work has explored the impact of psychosocial factors and modifiable interventions on pregnancy outcomes, incorporating cellular immune profiles to guide precision medicine strategies.

Publication(s)

PhD supervision

  • 2025 Biologically interpretable prediction of long-term disease risk ELGOHARY Kareem